Skip to content

CYCLERION THERAPEUTICS, INC.

CYCN

CIK 0001755237

← back to feed
Revenue (TTM)
$3.56M
−49.1% YoY Q1 May 2026
Net Income (TTM)
−$5.91M
−15.4% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.73
+8.3% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-206.2%
Q1 May 2026
Net Margin
-165.9%
Q1 May 2026
Free Cash Flow (TTM)
−$13.51M
Q1 May 2026
Cash
$2.82M
Q1 May 2026
Total Debt
$3.5M
Q1 May 2026
Shares Outstanding
4.33M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings